<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transmed</journal-id><journal-title-group><journal-title xml:lang="ru">Трансляционная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Translational Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-4495</issn><issn pub-type="epub">2410-5155</issn><publisher><publisher-name>Almazov National Medical Research Centre, Saint Petersburg, Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2311-4495-2025-12-2-114-124</article-id><article-id custom-type="edn" pub-id-type="custom">CZWTSM</article-id><article-id custom-type="elpub" pub-id-type="custom">transmed-1006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЕРДЕЧНО-СОСУДИСТЫЕ ЗАБОЛЕВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CARDIOVASCULAR MEDICINE</subject></subj-group></article-categories><title-group><article-title>Особенности течения постинфарктного периода у пациентов с неблагоприятным ремоделированием левого желудочка</article-title><trans-title-group xml:lang="en"><trans-title>Features of the course of the postinfarction period in patients with adverse left ventricular remodeling</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7130-0316</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Салямова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Salyamova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Салямова Людмила Ивановна - к.м.н., доцент, доцент кафедры «Терапия».</p><p>Пенза</p></bio><bio xml:lang="en"><p>Lyudmila I. Salyamova - Candidate of Medical Sciences, Associate Professor, Associate Professor of Therapy Department, Penza State University.</p><p>Penza</p></bio><email xlink:type="simple">l.salyamova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7008-6995</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Квасова</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kvasova</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Квасова Ольга Геннадьевна - к.м.н., доцент кафедры «Терапия».</p><p>Пенза</p></bio><bio xml:lang="en"><p>Olga G. Kvasova - Candidate of Medical Sciences, Associate Professor of Therapy Department, Penza State University.</p><p>Penza</p></bio><email xlink:type="simple">olhakvasova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6640-6108</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голубева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Golubeva</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Голубева Алена Владимировна - к.м.н., старший преподаватель кафедры «Терапия».</p><p>Пенза</p></bio><bio xml:lang="en"><p>Alyona V. Golubeva - Candidate of Medical Sciences, Senior Lecturer of Therapy Department, Penza State University.</p><p>Penza</p></bio><email xlink:type="simple">fialmy@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алимов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Alimov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алимов Николай Витальевич - студент 6 курса лечебного факультета.</p><p>Пенза</p></bio><bio xml:lang="en"><p>Nikolay V. Alimov - 6th year student, Faculty of Medicine, Penza State University.</p><p>Penza</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7463-9259</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олейников</surname><given-names>В. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Oleynikov</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олейников Валентин Эливич - д.м.н., профессор, заведующий кафедрой «Терапия».</p><p>ул. Красная, д. 40, Пенза, 440026</p></bio><bio xml:lang="en"><p>Valentin E. Oleynikov = Doctor of Medical Sciences, Professor, Head of Therapy Department, Penza State University.</p><p>Krasnaya str., 40, Penza, 440026</p></bio><email xlink:type="simple">v.oleynikof@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Пензенский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Penza State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>17</day><month>07</month><year>2025</year></pub-date><volume>12</volume><issue>2</issue><fpage>114</fpage><lpage>124</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Салямова Л.И., Квасова О.Г., Голубева А.В., Алимов Н.В., Олейников В.Э., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Салямова Л.И., Квасова О.Г., Голубева А.В., Алимов Н.В., Олейников В.Э.</copyright-holder><copyright-holder xml:lang="en">Salyamova L.I., Kvasova O.G., Golubeva A.V., Alimov N.V., Oleynikov V.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://transmed.almazovcentre.ru/jour/article/view/1006">https://transmed.almazovcentre.ru/jour/article/view/1006</self-uri><abstract><sec><title> </title><p> </p></sec><sec><title>Актуальность</title><p>Актуальность. Неблагоприятное ремоделирование левого желудочка (НРЛЖ) после инфаркта миокарда с подъемом сегмента ST (ИМпST) ассоциировано с высоким риском осложнений. Цель. Выявление лабораторных показателей, структурно-функциональных характеристик артерий, связанных с НРЛЖ после ИМпST и реваскуляризации. Материалы и методы. Включен 141 пациент. На 7–9-е сутки, через 24–48 недель проводили обследование. Конечные точки регистрировали в течение 192 недель. Результаты. Завершили наблюдение 125 больных, которых разделили на группы: 1-я «НРЛЖ» — 63 пациента с увеличением индекса конечного диастолического объема &gt; 20 % и/или индекса конечного систолического объема на &gt; 15 %; 2-я группа «Без НРЛЖ» — 62 человека. Через 48 недель в 1-й группе у больных со скоростью клубочковой фильтрации (рСКФ) &lt; 90 мл/мин/1,73 м2 показатель увеличился на 12,2 %; у лиц с исходной рСКФ ≥ 90 мл/мин/1,73 м2 она снизилась на 18,7 %. У больных «Без НРЛЖ» и исходной рСКФ &lt; 90 мл/мин/1,73 м2 показатель повысился на 6,2 %. Только во 2-й группе улучшились показатели эндотелиальной функции. Отношение шансов неблагоприятных событий в 1-й группе составило 2,8 [1,3–6,1] по сравнению со 2-й (р = 0,007). Заключение. Развитие НРЛЖ после ИМпST в среднесрочном периоде характеризовалось ухудшением фильтрационной способности почек и сохраняющейся эндотелиальной дисфункцией в течение 48 недель, высокой частотой неблагоприятных событий на протяжении 192 недель.</p></sec></abstract><trans-abstract xml:lang="en"><p>Background. Adverse left ventricular remodeling (ALVR) after ST-segment elevation myocardial infarction (STEMI) is associated with the high risk of complications. Objective. Identification of laboratory parameters, structural and functional characteristics of arteries associated with ALVR after STEMI and revascularization. Design and methods. 141 patients were included. On days 7–9, after 24–48 weeks, an examination was performed. The endpoints were recorded for 192 weeks. Results. 125 patients were followed up, who were divided into groups: 1st “ALVR” — 63 patients with an increase in end-diastolic volume index by &gt; 20 % and/ or end-systolic volume index by &gt; 15 %; 2nd group “Without ALVR” — 62 people. After 48 weeks, in the 1st group, in patients with glomerular filtration rate (eGFR) &lt; 90 ml/min/1.73 m2, the indicator increased by 12.2 %; in individuals with an initial eGFR ≥ 90 ml/min/1.73 m2, it decreased by 18.7 %. In patients without ALVR and initial eGFR &lt; 90 ml/min/1.73 m2, the indicator increased by 6.2 %. Only in group 2, positive dynamics of endothelial function indicators was revealed. The odds ratio of adverse events in group 1 was 2.8 [1.3–6.1] compared with group 2 (p = 0.007). Conclusion. The development of ALVR after MI in the medium term was characterized by a deterioration in the filtration capacity of the kidneys and persistent endothelial dysfunction over 48 weeks, a high incidence of adverse events over 192 weeks.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>аортальное давление</kwd><kwd>инфаркт миокарда с подъемом сегмента ST</kwd><kwd>конечные точки</kwd><kwd>неблагоприятное ремоделирование левого желудочка</kwd><kwd>скорость клубочковой фильтрации</kwd><kwd>эндотелиальная функция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>adverse left ventricle remodeling</kwd><kwd>aortic pressure</kwd><kwd>endothelial function</kwd><kwd>endpoints</kwd><kwd>glomerular filtration rate</kwd><kwd>ST-segment elevation myocardial infarction</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счет средств гранта Российского научного фонда, проект № 23-75-01078.</funding-statement><funding-statement xml:lang="en">The research was carried out at the expense of a grant from the Russian Science Foundation, project No. 23-75-01078.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Здравоохранение в России. 2023: Стат.сб./Росстат. М., 2023. 179 с.</mixed-citation><mixed-citation xml:lang="en">Health care in Russia. 2023: Stat.sb./Rosstat. 2023:179. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Alkhalil M, Choudhury RP. Reperfusion Treatment in Late Presentation Acute Myocardial Infarction: Timing Is Not Everything. Circulation: Cardiovascular Interventions. 2018; 11(9):e007287. DOI:10.1161/CIRCINTERVENTIONS.118.007287.</mixed-citation><mixed-citation xml:lang="en">Alkhalil M, Choudhury RP. Reperfusion Treatment in Late Presentation Acute Myocardial Infarction: Timing Is Not Everything. Circulation: Cardiovascular Interventions. 2018; 11(9):e007287. DOI:10.1161/CIRCINTERVENTIONS.118.007287.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">The World Heart Federation, Severin T, Champagne B, et al. World Heart Vision 2030: Driving Policy Change. Geneva, Switzerland. 2022.</mixed-citation><mixed-citation xml:lang="en">The World Heart Federation, Severin T, Champagne B, et al. World Heart Vision 2030: Driving Policy Change. Geneva, Switzerland. 2022.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Frantz S, Hundertmark MJ, Schulz-Menger J, et al. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43(27):2549–2561. DOI:10.1093/eurheartj/ehac223.</mixed-citation><mixed-citation xml:lang="en">Frantz S, Hundertmark MJ, Schulz-Menger J, et al. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43(27):2549–2561. DOI:10.1093/eurheartj/ehac223.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020; 141:e139– e596. DOI:10.1161/CIR.0000000000000757.</mixed-citation><mixed-citation xml:lang="en">Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020; 141:e139–e596. DOI:10.1161/CIR.0000000000000757.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Bai M, Deng A, et al. Evaluation of Left Ventricular Remodeling and Prognosis after PCI in Acute Myocardial Infarction Using Real-Time, Three-Dimensional Echocardiography Combined with Layer-Specific Strain Imaging. Heart Surgery Forum. 2024;27(9):E1017–E1028. DOI:10.59958/hsf.7705.</mixed-citation><mixed-citation xml:lang="en">Zhang L, Bai M, Deng A, et al. Evaluation of Left Ventricular Remodeling and Prognosis after PCI in Acute Myocardial Infarction Using Real-Time, Three-Dimensional Echocardiography Combined with Layer-Specific Strain Imaging. Heart Surgery Forum. 2024;27(9):E1017–E1028. DOI:10.59958/hsf.7705.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">van der Bijl P, Abou R, Goedemans L, et al. Left Ventricular Post-Infarct Remodeling: Implications for Systolic Function Improvement and Outcomes in the Modern Era. JACC Heart Fail. 2020;8(2):131–140. DOI:10.1016/j.jchf.2019.08.014.</mixed-citation><mixed-citation xml:lang="en">van der Bijl P, Abou R, Goedemans L, et al. Left Ventricular Post-Infarct Remodeling: Implications for Systolic Function Improvement and Outcomes in the Modern Era. JACC Heart Fail. 2020;8(2):131–140. DOI:10.1016/j.jchf.2019.08.014.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Baylis RA, Gomez D, Mallat Z, et al. The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology. Arterioscler Thromb Vasc Biol. 2017;37(11):e174–e177. DOI:10.1161/ATVBAHA.117.310097.</mixed-citation><mixed-citation xml:lang="en">Baylis RA, Gomez D, Mallat Z, et al. The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology. Arterioscler Thromb Vasc Biol. 2017;37(11):e174–e177. DOI:10.1161/ATVBAHA.117.310097.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Четвертое универсальное определение инфаркта миокарда (2018). Российский кардиологический журнал. 2019;24(3):107–138. DOI: 10.15829/1560-4071-2019-3-107-138.</mixed-citation><mixed-citation xml:lang="en">Fourth universal definition of myocardial infarction (2018). Russian Journal of Cardiology. 2019;24(3):107–138. In Russian. DOI: 10.15829/1560-4071-2019-3-107-138.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации ЕОК по ведению пациентов с острым инфарктом миокарда с подъемом сегмента ST 2017. Российский кардиологический журнал. 2018;23(5):103–158. DOI:10.15829/1560-4071-2018-5-103-158.</mixed-citation><mixed-citation xml:lang="en">The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Russian Journal of Cardiology. 2018;(5):103–158. In Russian. DOI:10.15829/1560-4071-2018-5-103-158.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Алекян Б.Г., Бойцов С.А., Маношкина Е.М. и др. Реваскуляризация миокарда в Российской Федерации при остром коронарном синдроме в 2016–2020 гг. Кардиология. 2021;61(12):4–15. DOI:10.18087/CARDIO.2021.12.N1879.</mixed-citation><mixed-citation xml:lang="en">Alekyan BG, Boytsov SA, Manoshkina EM, et al. Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016–2020. Cardiology. 2021;61(12):4–15. In Russian DOI:10.18087/CARDIO.2021.12.N1879.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cokkinos DV, Belogianneas C. Left Ventricular Remodelling: A Problem in Search of Solutions. Eur Cardiol. 2016;11(1):29–35. DOI:10.15420/ecr.2015:9:3.</mixed-citation><mixed-citation xml:lang="en">Cokkinos DV, Belogianneas C. Left Ventricular Remodelling: A Problem in Search of Solutions. Eur Cardiol. 2016;11(1):29–35. DOI:10.15420/ecr.2015:9:3.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Świątkiewicz I, Magielski P, Kubica J. C-Reactive Protein as a Risk Marker for Post Infarct Heart Failure over a Multi Year Period. Int J Mol Sci. 2021;22(6):3169. DOI:10.3390/ijms22063169.</mixed-citation><mixed-citation xml:lang="en">Świątkiewicz I, Magielski P, Kubica J. C-Reactive Protein as a Risk Marker for Post Infarct Heart Failure over a Multi Year Period. Int J Mol Sci. 2021;22(6):3169. DOI:10.3390/ijms22063169.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodeling. Nat Rev Cardiol. 2014;11:255–65. DOI:10.1038/nrcardio.2014.28.</mixed-citation><mixed-citation xml:lang="en">Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodeling. Nat Rev Cardiol. 2014;11:255–65. DOI:10.1038/nrcardio.2014.28.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Генкель В.В., Кузнецова А.С., Салашенко А.О. и др. Увеличение уровня высокочувствительного С-реактивного белка как маркер мультифокального атеросклероза у пациентов с сердечно-сосудистыми заболеваниями. Медицинский совет. 2019;16:86–93. DOI:10.21518/2079-701X-2019-16-86-93.</mixed-citation><mixed-citation xml:lang="en">Genkel VV, Kuznetcova AS, Salashenko AO, et al. Increase in high-sensitive C-reactive protein as a marker of polyvascular disease in patients with cardiovascular diseases. Meditsinskiy sovet=Medical Council. 2019;(16):87–93. In Russian. DOI:10.21518/2079-701X-2019-16-86-93.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Li G, Qi G, Zhang B, et al. The dose-response association between estimated glomerular filtration rate and prognosis of patients with ST-segment elevation myocardial infarction from rural areas of China’s Liaoning province. Medicine (Baltimore). 2017;96(52):e9508. DOI:10.1097/MD.0000000000009508.</mixed-citation><mixed-citation xml:lang="en">Li G, Qi G, Zhang B, et al. The dose-response association between estimated glomerular filtration rate and prognosis of patients with ST-segment elevation myocardial infarction from rural areas of China’s Liaoning province. Medicine (Baltimore). 2017;96(52):e9508. DOI:10.1097/MD.0000000000009508.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Резник Е.В., Никитин И.Г. Кардиоренальный синдром у больных с сердечной недостаточностью как этап кардиоренального континуума (часть I): определение, классификация, патогенез, диагностика, эпидемиология (обзор литературы). Архивъ внутренней медицины. 2019;9(1):5–22. DOI:10.20514/2226-6704-2019-9-1-5-22.</mixed-citation><mixed-citation xml:lang="en">Reznik EV, Nikitin IG. Cardiorenal syndrome in patients with chronic heart failure as a stage of the cardiorenal continuum (part I): definition, classification, pathogenesis, diagnosis, epidemiology. The Russian Archives of Internal Medicine. 2019;9(1):5–22. In Russian. DOI:10.20514/2226-6704-2019-9-1-5-22.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaoka-Tojo M. Endothelial Function for Cardiovascular Disease Prevention and Management. Int J Clin Cardiol. 2017;4(3):103. DOI:10.23937/2378-2951/1410103.</mixed-citation><mixed-citation xml:lang="en">Yamaoka-Tojo M. Endothelial Function for Cardiovascular Disease Prevention and Management. Int J Clin Cardiol. 2017;4(3):103. DOI:10.23937/2378-2951/1410103.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta N, Giri S, Rathi V, et al. Flow Mediated Dilatation, Carotid Intima Media Thickness, Ankle Brachial Pressure Index and Pulse Pressure in Young Male Post Myocardial Infarction Patients in India. J Clin Diagn Res. 2016;10(10):OC35–OC39. DOI:10.7860/JCDR/2016/20872.8751.</mixed-citation><mixed-citation xml:lang="en">Gupta N, Giri S, Rathi V, et al. Flow Mediated Dilatation, Carotid Intima Media Thickness, Ankle Brachial Pressure Index and Pulse Pressure in Young Male Post Myocardial Infarction Patients in India. J Clin Diagn Res. 2016;10(10):OC35–OC39. DOI:10.7860/JCDR/2016/20872.8751.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Мельникова Ю.С., Макарова Т.П. Эндотелиальная дисфункция как центральное звено патогенеза хронических болезней. Казанский медицинский журнал. 2015;96 (4):659–665.</mixed-citation><mixed-citation xml:lang="en">Melnikova YuS, Makarova TP. Endothelial dysfunction as a central link in the pathogenesis of chronic diseases. Kazan Medical Journal. 2015;96(4):659–665. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Giannitsi, S, Bougiakli M, Bechlioulis A, et al. Endothelial dysfunction and heart failure: A review of the existing bibliography with emphasis on flow mediated dilation. JRSM Cardiovasc Dis. 2019;8:1–7. DOI:10.1177/2048004019843047/.</mixed-citation><mixed-citation xml:lang="en">Giannitsi, S, Bougiakli M, Bechlioulis A, et al. Endothelial dysfunction and heart failure: A review of the existing bibliography with emphasis on flow mediated dilation. JRSM Cardiovasc Dis. 2019;8:1–7. DOI:10.1177/2048004019843047/.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Luxán G, Dimmeler S. The vasculature: a therapeutic target in heart failure? Cardiovascular Research. 2022;118:53–64. DOI:10.1093/cvr/cvab047.</mixed-citation><mixed-citation xml:lang="en">Luxán G, Dimmeler S. The vasculature: a therapeutic target in heart failure? Cardiovascular Research. 2022;118:53–64. DOI:10.1093/cvr/cvab047.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Talman, V, Kivelä R. Cardiomyocyte — Endothelial Cell Interactions in Cardiac Remodeling and Regeneration. Front. Cardiovasc. Med. 2018;26(5):101. DOI:10.3389/fcvm.2018.00101.</mixed-citation><mixed-citation xml:lang="en">Talman, V, Kivelä R. Cardiomyocyte — Endothelial Cell Interactions in Cardiac Remodeling and Regeneration. Front. Cardiovasc. Med. 2018;26(5):101. DOI:10.3389/fcvm.2018.00101.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
